GSA Capital Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.28M	Buy	+318,732	New	+$1.28M	0.09%	321
2025 Q1	–	Sell	-36,096	Closed	-$193K	–	1728
2024 Q4	$193K	Buy	+36,096	New	+$193K	0.01%	1422
2021 Q2	–	Sell	-95,613	Closed	-$294K	–	1354
2021 Q1	$294K	Buy	+95,613	New	+$294K	0.05%	657